NKGen Biotech Receives Nasdaq Non-Compliance Notice For Market Value Of Publicly Held Shares Below $15M Minimum, Plans To Monitor And Explore Options To Regain Compliance
NKGen Biotech Receives Nasdaq Non-Compliance Notice For Market Value Of Publicly Held Shares Below $15M Minimum, Plans To Monitor And Explore Options To Regain Compliance
NKGen生物科技收到納斯達克未達到市值低於1500萬美元的公開持股通知，計劃監測並探索恢復符合性的期權
NKGen Biotech Receives Nasdaq Non-Compliance Notice For Market Value Of Publicly Held Shares Below $15M Minimum, Plans To Monitor And Explore Options To Regain Compliance
NKGen Biotech 收到納斯達克的不合規通知，因公開持有的股份市值低於1500萬美元的最低限額，計劃進行監測並探索期權以恢復合規。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
資訊熱榜
更新時間